Originally published in HCPLive.com
by Anita Ramsetty, MD
We are very fortunate to have a number of newer insulins available for our patients.
For years we had animal insulins only. NPH and Regular, then we had Ultralente. The development of analog insulins marked the upswing in technology that we would sustain for a period of time. The most recent big blip in the …